Cryptosporidiosis
27
2
3
16
Key Insights
Highlights
Success Rate
76% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
18.5%
5 terminated out of 27 trials
76.2%
-10.3% vs benchmark
7%
2 trials in Phase 3/4
6%
1 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (27)
Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults
Nitazoxanide for Treatment of Cryptosporidium in Children
Cryptosporidiosis and Enteropathogens in Bangladesh
Cryptosporidium Species in Sohag Governorate
Cryptosporidium Infection and Human Colorectal Cancer
Treatment of Cryptosporidiosis
A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3
A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium
Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children
A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis
Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events
Parasitic Infections of the Gastrointestinal Tract
Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients
Treatment of Chronic Cryptosporidiosis in AIDS Patients
Transmission and the Respiratory Tract in Cryptosporidiosis
A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis
Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs
A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea
Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients